Automated and Guided Workflows for Clinical Testing Using NGS Assays
Automated and Guided Workflows for Clinical Testing Using NGS Assays
批准号:
9894817
负责人:
Andreas Scherer
金额:
$64.97万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-03-15 至 2021-02-28
关键词:
AccountabilityAdoptedAdoptionAlgorithmsAmericanAppropriateness ReviewAutomationBenchmarkingBioinformaticsBiological AssayClassificationClinicalClinical Laboratory Improvement AmendmentsClinical assessmentsCollaborationsCommunicationCompetenceComplexComplex AnalysisComputer softwareCopy Number PolymorphismDataData SourcesDecision Support SystemsDependenceDetectionDevelopmentDiagnosisElementsEnsureEnvironmentFutureGeneticGenetic ScreeningGenetic ServicesGenomicsGovernmentGuidelinesHandHereditary DiseaseHuman ResourcesIndividualIndustryIndustry StandardInformaticsInheritedInstitutionJudgmentKnowledgeLaboratoriesMalignant NeoplasmsMedicalMedical GeneticsMutationNewborn InfantNucleotidesOutcomeOutputPatient-Focused OutcomesPatientsPersonal SatisfactionPhasePositioning AttributePrivatizationProceduresProcessRare DiseasesReportingResourcesRisk AssessmentRunningSamplingSingle Nucleotide PolymorphismSmall Business Innovation Research GrantSourceSpecialistSystemTalentsTestingTimeTrainingVariantWorkanalysis pipelinebaseblindcostdata hostingdata integrationdata warehousedesigndisease diagnosisgenetic associationgenetic testinggenetic variantgenomic datagenomic variationimprovedin silicomedical schoolsmolecular pathologynext generation sequencingprecision medicinepressureprototypereproductiveresearch clinical testingsecondary analysissuccesstesting servicestooltumorweb app
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The work done in a genetic laboratory to process a sample requires many detailed-oriented steps and a wealth
of individual and institutional knowledge. The output of this process often has a significant impact on a patient’s
outcome and wellbeing. At the same time, the work is repetitive and requires the handling of large test volumes
under the time pressures inherent in medical procedures. This is particularly the case with next-generation
sequencing (NGS) based tests, which are increasingly used to diagnose rare diseases, analyze mutation profiles
of tumors, offer reproductive genetic services and perform newborn genetic screening. Existing software solution
in this space have taken steps to make the overall work for a clinician simpler. Still, the efforts have not addressed
the dependency on expert judgment and the following of detailed and often complex procedures to complete a
genetic test. This environment lends itself to the application of workflow automation capabilities. The key benefits
for the clinical users are the following:
1. Minimizing the potential for error: Workflow automation ensures essential and necessary tasks from
going unnoticed. With tasks and the personnel that perform them being compressively tracked, workflow
automation saves labs from far reaching and potentially very costly expenses associated with lab
personnel errors.
2. Reducing costs and increasing throughput: Integrating internal communication into the workflow
platform reduces the overhead required to conduct clinical work and stay compliant. The result is more
work can be done with the same personnel.
3. Creating accountability and reducing subjectivity: As the complex rules and institutional knowledge
of a laboratory gets codified into a workflow, every analytical step can be assigned and attributed to
individual lab personnel while reducing the amount of choices made outside the system also reduces
variance of outcomes attributed to operator subjectivity.
In this project, we bring all elements of the clinical workflow for next-generation sequencing together. This
includes the detection of single nucleotide variations and copy number variations, the annotation and clinical
assessment of those variants, the storing of the finalized report and all associated data in a genetic data
warehouse. This project will also cover the automation of the informatics that enable a decision support system
capable of implementing variant classification guidelines such as those by the American College of Medical
Genetics, Association of Molecular Pathology and other leading industry bodies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pharmacogenomics Workflow: Identifying Biomarkers and Treatment Options
-
批准号:10819933
-
项目类别:
-
资助金额:$39.98万
-
财政年份:2023
-
负责人:Andreas Scherer
-
依托单位:
Integrating CNV analysis into a NextGen sequencing clinical analytics platform
-
批准号:9408437
-
项目类别:
-
资助金额:$15.0万
-
财政年份:2017
-
负责人:Andreas Scherer
-
依托单位:
海外基金